BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36499654)

  • 1. Osteopontin Splicing Isoforms Contribute to Endometriotic Proliferation, Migration, and Epithelial-Mesenchymal Transition in Endometrial Epithelial Cells.
    Ho NT; Lin SW; Lee YR; Tzeng CR; Kao SH
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells.
    Nakamura KD; Tilli TM; Wanderley JL; Palumbo A; Mattos RM; Ferreira AC; Klumb CE; Nasciutti LE; Gimba ER
    Tumour Biol; 2016 Feb; 37(2):2655-63. PubMed ID: 26404131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells.
    Tilli TM; Mello KD; Ferreira LB; Matos AR; Accioly MT; Faria PA; Bellahcène A; Castronovo V; Gimba ER
    Prostate; 2012 Nov; 72(15):1688-99. PubMed ID: 22495819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer.
    Goparaju CM; Pass HI; Blasberg JD; Hirsch N; Donington JS
    J Thorac Oncol; 2010 Oct; 5(10):1516-23. PubMed ID: 20689445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin-c splicing isoform contributes to ovarian cancer progression.
    Tilli TM; Franco VF; Robbs BK; Wanderley JL; da Silva FR; de Mello KD; Viola JP; Weber GF; Gimba ER
    Mol Cancer Res; 2011 Mar; 9(3):280-93. PubMed ID: 21263033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma.
    Lin J; Myers AL; Wang Z; Nancarrow DJ; Ferrer-Torres D; Handlogten A; Leverenz K; Bao J; Thomas DG; Wang TD; Orringer MB; Reddy RM; Chang AC; Beer DG; Lin L
    Oncotarget; 2015 Sep; 6(26):22239-57. PubMed ID: 26068949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin inhibits 17β-estradiol-induced migration, invasion and epithelial-mesenchymal transition in normal and endometriotic endometrial epithelial cells.
    Qi S; Yan L; Liu Z; Mu YL; Li M; Zhao X; Chen ZJ; Zhang H
    Reprod Biol Endocrinol; 2018 Jun; 16(1):62. PubMed ID: 29935526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin‑c isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticity.
    Brum MCM; Dos Santos Guimaraes I; Ferreira LB; Rangel LBA; Maia RC; Nestal De Moraes G; Gimba ERP
    Oncol Rep; 2021 Feb; 45(2):652-664. PubMed ID: 33416171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin Regulates Endometrial Stromal Cell Migration in Endometriosis through the PI3K Pathway : Osteopontin Regulates Endometrial Cell Migration in Endometriosis.
    Fu X; Yao M; Ye C; Fang T; Wu R
    Reprod Sci; 2021 Feb; 28(2):435-446. PubMed ID: 32909189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-126-5p downregulates BCAR3 expression to promote cell migration and invasion in endometriosis.
    Meng X; Liu J; Wang H; Chen P; Wang D
    Mol Cell Endocrinol; 2019 Aug; 494():110486. PubMed ID: 31233772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of Lysyl Oxidase Expression in Lesions and Endometrium of Women With Endometriosis.
    Ruiz LA; Báez-Vega PM; Ruiz A; Peterse DP; Monteiro JB; Bracero N; Beauchamp P; Fazleabas AT; Flores I
    Reprod Sci; 2015 Dec; 22(12):1496-508. PubMed ID: 25963914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression pattern of osteopontin isoforms in malignant melanoma cell lines.
    Koroknai V; Szász I; Jámbor K; Balázs M
    Clin Transl Sci; 2024 Jan; 17(1):e13694. PubMed ID: 38058256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar Characteristics of Endometrial and Endometriotic Epithelial Cells.
    Konrad L; Gronbach J; Horné F; Mecha EO; Berkes E; Frank M; Gattenlöhner S; Omwandho COA; Oehmke F; Tinneberg HR
    Reprod Sci; 2019 Jan; 26(1):49-59. PubMed ID: 29402201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of osteopontin and matrix metalloproteinase- 9 in the migration of endometrial epithelial cells in patients with endometriosis.
    Yang M; Jiang C; Chen H; Nian Y; Bai Z; Ha C
    Reprod Biol Endocrinol; 2015 Aug; 13():95. PubMed ID: 26289107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced epithelial to mesenchymal transition (EMT) and upregulated MYC in ectopic lesions contribute independently to endometriosis.
    Proestling K; Birner P; Gamperl S; Nirtl N; Marton E; Yerlikaya G; Wenzl R; Streubel B; Husslein H
    Reprod Biol Endocrinol; 2015 Jul; 13():75. PubMed ID: 26198055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology.
    Guo SW
    Hum Reprod Update; 2020 Apr; 26(3):423-449. PubMed ID: 32154564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin isoforms differentially promote arteriogenesis in response to ischemia via macrophage accumulation and survival.
    Lee GS; Salazar HF; Joseph G; Lok ZSY; Caroti CM; Weiss D; Taylor WR; Lyle AN
    Lab Invest; 2019 Mar; 99(3):331-345. PubMed ID: 29959420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin (OPN) isoforms, diabetes, obesity, and cancer; what is one got to do with the other? A new role for OPN.
    Sarosiek K; Jones E; Chipitsyna G; Al-Zoubi M; Kang C; Saxena S; Gandhi AV; Sendiky J; Yeo CJ; Arafat HA
    J Gastrointest Surg; 2015 Apr; 19(4):639-50. PubMed ID: 25583441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the transcriptional profile in response to overexpression of the osteopontin-c splice isoform in ovarian (OvCar-3) and prostate (PC-3) cancer cell lines.
    Tilli TM; Bellahcène A; Castronovo V; Gimba ER
    BMC Cancer; 2014 Jun; 14():433. PubMed ID: 24928374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin-driven partial epithelial-mesenchymal transition governs the development of middle ear cholesteatoma.
    Zeng L; Xie L; Hu J; He C; Liu A; Lu X; Zhou W
    Cell Cycle; 2024 Mar; 23(5):537-554. PubMed ID: 38662954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.